whew! the guys on the other board had me convinced that
whew! the guys on the other board had me convinced that this was bankruptcy for sure. The walls are closing in. Really... this time they mean it. The walls really are closing in. Bombshell development. Its only a matter of time!
its a big circle jerk over there with them feeding off themselves, yelling into the ether while we continue on knowing the day will come when they are proven wrong and all the false allegations thrown at cytodyn are shown to be just manipulation. Sometimes it reminds me of the movie the exorcist when demons fight the hardest right before they are exorcized.
The people that dont want to see what a gamechanger LL will be and know that it is upsetting the current order of the pharma industry are making their intentions obvious by their crazy allegations and actions. We got a brief glimpse of LL greatness for several months during covid, and eventually all the underhanded dealings will come to light about how much misinformation and collusion to prevent LL from bringing about better lives for all.
Unfortunately, not the only story of its kind in this world.
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...
Continue Reading
Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...
Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...
Continue Reading
Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...
Continue Reading
Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....
Continue Reading